173034-70-3 Usage
Description
[1-(1'(R)-ALPHA-METHYLBENZYL)-AZIRIDIN-2(R)-YL]-METHANOL is a complex chemical compound characterized by the presence of an aziridine ring—a three-membered heterocycle with one nitrogen atom. The incorporation of an alpha-methylbenzyl group and the aziridin-2(R)-yl group suggests potential biological activity, making it a candidate for pharmaceutical applications. The methanol group attached to the aziridine ring indicates solubility in polar solvents, broadening its potential uses across various scientific fields.
Uses
Used in Pharmaceutical Applications:
[1-(1'(R)-ALPHA-METHYLBENZYL)-AZIRIDIN-2(R)-YL]-METHANOL is used as a pharmaceutical agent for its potential biological activity, which may include interactions with biological targets important for therapeutic effects.
Used in Chemical Research:
In the field of chemical research, [1-(1'(R)-ALPHA-METHYLBENZYL)-AZIRIDIN-2(R)-YL]-METHANOL serves as a subject for studying the properties and reactions of complex organic molecules, particularly those containing aziridine rings and alpha-methylbenzyl groups.
Used in Materials Science:
[1-(1'(R)-ALPHA-METHYLBENZYL)-AZIRIDIN-2(R)-YL]-METHANOL is utilized in materials science for exploring its potential in the development of new materials, possibly due to its solubility and reactivity, which could be harnessed for creating novel polymers or other advanced materials.
Check Digit Verification of cas no
The CAS Registry Mumber 173034-70-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,3,0,3 and 4 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 173034-70:
(8*1)+(7*7)+(6*3)+(5*0)+(4*3)+(3*4)+(2*7)+(1*0)=113
113 % 10 = 3
So 173034-70-3 is a valid CAS Registry Number.
InChI:InChI=1/C11H15NO/c1-9(12-7-11(12)8-13)10-5-3-2-4-6-10/h2-6,9,11,13H,7-8H2,1H3/t9-,11-,12?/m1/s1
173034-70-3Relevant articles and documents
SPHINGOLIPID DERIVATIVES AND THE COMPOSITION FOR ANTI-CANCER CONTAINING THE SAME
-
Page/Page column 14; 20, (2010/02/15)
Disclosed are a novel sphingolipid derivative having a sphingosine kinase suppressing activity and a composition containing the same. When the newly synthesized sphingolipid derivative of the invention is used, it is possible to maintain concentrations of ceramide and sphingosine to be high by preventing ceramide and sphingosine from being phosphorylated due to sphingosine kinase since an activity of sphingosine kinase is suppressed. In addition, since the apoptosis is induced in a cancer cell by ceramide and sphingosine, it is possible to treat or prevent a cancer or disease related to the cancer. Further, it is possible to treat or prevent a hyper- proliferative disease such as cancer or proliferation-promoting activity of sphingosine kinase. Accordingly, the composition containing the same can be used as a composition for suppressing sphingosine kinase and a composition for treating or preventing a cancer or hyper-proliferative disease.